CB1 receptor expression changed in brain immune cells of an Alzheimer's mouse model
In the subiculum of Alzheimer's disease model mice, CB1 receptor expression increased in reactive microglia but remained proportionally constant in astrocytes, suggesting distinct glial endocannabinoid responses to amyloid pathology.
Quick Facts
What This Study Found
CB1 receptor expression increased in reactive microglia surrounding amyloid plaques in the subiculum of 5xFAD mice. In astrocytes, CB1 labeling rose proportionally to cell size (reactive astrocytes are larger), keeping receptor density effectively constant.
Key Numbers
CB1 receptor expression increased in reactive microglia in 5xFAD mice vs. controls. In astrocytes, CB1 labeling increased proportionally to perimeter of reactive astrocytes. Microglial CB1 was found closely surrounding amyloid plaques and dystrophic neurites.
How They Did This
Immuno-electron microscopy examining CB1 receptor localization in microglia and astrocytes in the subiculum of 5xFAD/CB2-EGFP mice (Alzheimer's model) versus controls. Quantitative analysis of receptor density relative to glial cell morphology.
Why This Research Matters
The endocannabinoid system is involved in neuroinflammation, and understanding how CB1 receptors change in glial cells during Alzheimer's pathology could identify therapeutic targets for modulating the neuroinflammatory response.
The Bigger Picture
Neuroinflammation driven by microglia and astrocytes is increasingly recognized as a key driver of Alzheimer's progression. The endocannabinoid system modulates this inflammatory response, making it a potential intervention point for slowing disease.
What This Study Doesn't Tell Us
Mouse model of Alzheimer's disease (5xFAD) overexpresses mutant human genes and may not fully recapitulate human AD pathology. Observational study of receptor expression without functional testing. Only examined the subiculum, one of many affected brain regions.
Questions This Raises
- ?Does the increase in microglial CB1 expression serve a protective or pathological role?
- ?Would CB1 modulation in microglia alter amyloid plaque progression or neuroinflammation?
Trust & Context
- Key Stat:
- CB1 receptors increased in reactive microglia near amyloid plaques in Alzheimer's mice
- Evidence Grade:
- Well-executed electron microscopy study in a transgenic mouse model. Descriptive finding without functional or therapeutic testing.
- Study Age:
- Published 2023.
- Original Title:
- Altered glial expression of the cannabinoid 1 receptor in the subiculum of a mouse model of Alzheimer's disease.
- Published In:
- Glia, 71(4), 866-879 (2023)
- Authors:
- Terradillos, Itziar, Bonilla-Del Río, Itziar, Puente, Nagore(2), Serrano, Maitane, Mimenza, Amaia, Lekunberri, Leire, Anaut-Lusar, Ilazki, Reguero, Leire, Gerrikagoitia, Inmaculada, Ruiz de Martín Esteban, Samuel, Hillard, Cecilia J, Grande, María T, Romero, Julián, Elezgarai, Izaskun, Grandes, Pedro
- Database ID:
- RTHC-04978
Evidence Hierarchy
Frequently Asked Questions
What does this mean for cannabis and Alzheimer's?
This study shows that cannabinoid receptors change in brain immune cells during Alzheimer's-like pathology in mice. It does not test whether cannabis or cannabinoids would help or harm Alzheimer's patients. It identifies the endocannabinoid system as involved in the brain's inflammatory response to amyloid plaques.
What are microglia and why do they matter in Alzheimer's?
Microglia are the brain's resident immune cells. In Alzheimer's disease, they cluster around amyloid plaques and become "reactive," producing inflammatory molecules. This neuroinflammation is thought to accelerate brain damage. Understanding how cannabinoid receptors change in these cells could reveal new ways to modulate the harmful inflammatory response.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-04978APA
Terradillos, Itziar; Bonilla-Del Río, Itziar; Puente, Nagore; Serrano, Maitane; Mimenza, Amaia; Lekunberri, Leire; Anaut-Lusar, Ilazki; Reguero, Leire; Gerrikagoitia, Inmaculada; Ruiz de Martín Esteban, Samuel; Hillard, Cecilia J; Grande, María T; Romero, Julián; Elezgarai, Izaskun; Grandes, Pedro. (2023). Altered glial expression of the cannabinoid 1 receptor in the subiculum of a mouse model of Alzheimer's disease.. Glia, 71(4), 866-879. https://doi.org/10.1002/glia.24312
MLA
Terradillos, Itziar, et al. "Altered glial expression of the cannabinoid 1 receptor in the subiculum of a mouse model of Alzheimer's disease.." Glia, 2023. https://doi.org/10.1002/glia.24312
RethinkTHC
RethinkTHC Research Database. "Altered glial expression of the cannabinoid 1 receptor in th..." RTHC-04978. Retrieved from https://rethinkthc.com/research/terradillos-2023-altered-glial-expression-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.